Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Mann

Showing results (251-260 of 1,221) with videos related to

Pageof 123
Sort By:
JACC. Basic to Translational Science|August 1, 2018
Empagliflozin and the Prevention of Heart Failure: Will Reverse Translation Lead to New Paradigms for the Treatment of Heart Failure?Douglas L Mann, Daniel P Kelly
The Canadian Journal of Hospital Pharmacy|October 1, 1994
Drug utilization & therapeutic intervention programs: pharmacy services that pay for themselvesJ H Condron, J L Mann
Applied Ergonomics|December 1, 1986
Evaluation of formats for aircraft control/display unitsT L Mann, L A Schnetzler
JACC. Heart Failure|August 8, 2015
Light Chains and the Failing Heart: Important Mechanistic Link or Fifty Shades of Gray?James L Januzzi, Douglas L Mann
JACC. Basic to Translational Science|January 10, 2019
The Tafamidis Drug Development Program: A Translational TriumphMathew S Maurer, Douglas L Mann
Progress in Cardiovascular Diseases|August 24, 2010
Cardiac disease in cancer patients: an overviewDouglas L Mann, Ronald J Krone
Nature Reviews. Drug Discovery|May 1, 2013
Translational medicine: mitigating risks for investigatorsDouglas L Mann, Daria Mochly-Rosen
The Journal of the Oklahoma State Medical Association|October 1, 1977
Use of the clinical virology laboratoryT W Violett, S L Mann
Acta Anatomica|October 22, 1998
Glycocoding as an information management system in embryonic developmentP L Mann, R E Waterman
Arteriosclerosis, Thrombosis, and Vascular Biology|November 25, 2025
Cardio-Hematopoietic Axis in Cardiac Injury and Repair: From Adaptation to MaladaptationDouglas L Mann, Andrew I Schafer
Pageof 123

Showing results (251-260 of 1,221) with videos related to

Sort By:
Pageof 123
JACC. Basic to Translational Science|August 1, 2018
Empagliflozin and the Prevention of Heart Failure: Will Reverse Translation Lead to New Paradigms for the Treatment of Heart Failure?Douglas L Mann, Daniel P Kelly
The Canadian Journal of Hospital Pharmacy|October 1, 1994
Drug utilization & therapeutic intervention programs: pharmacy services that pay for themselvesJ H Condron, J L Mann
Applied Ergonomics|December 1, 1986
Evaluation of formats for aircraft control/display unitsT L Mann, L A Schnetzler
JACC. Heart Failure|August 8, 2015
Light Chains and the Failing Heart: Important Mechanistic Link or Fifty Shades of Gray?James L Januzzi, Douglas L Mann
JACC. Basic to Translational Science|January 10, 2019
The Tafamidis Drug Development Program: A Translational TriumphMathew S Maurer, Douglas L Mann
Progress in Cardiovascular Diseases|August 24, 2010
Cardiac disease in cancer patients: an overviewDouglas L Mann, Ronald J Krone
Nature Reviews. Drug Discovery|May 1, 2013
Translational medicine: mitigating risks for investigatorsDouglas L Mann, Daria Mochly-Rosen
The Journal of the Oklahoma State Medical Association|October 1, 1977
Use of the clinical virology laboratoryT W Violett, S L Mann
Acta Anatomica|October 22, 1998
Glycocoding as an information management system in embryonic developmentP L Mann, R E Waterman
Arteriosclerosis, Thrombosis, and Vascular Biology|November 25, 2025
Cardio-Hematopoietic Axis in Cardiac Injury and Repair: From Adaptation to MaladaptationDouglas L Mann, Andrew I Schafer
Pageof 123